News

NEWS
Publication
November 28, 2016
A New Mathematical Model of the Eosinophil Lifecycle Shows Irrelevance of the Asthma Biomarker Choice
Moscow, Russia - November 29th, 2016. Institute for Systems Biology Moscow (www.insysbio.ru), one of the pioneers in bio-modeling and simulation announced the study made in collaboration with scientists of two pharmaceutical leaders: MedImmune and AstraZeneca.
LEARN MORE
December 2024
MoTuWeThFrSaSu
      
1
2
3
4
5
1. 05 Dec 2024 14:59 The path of a Quantitative Systems Pharmacology company to optimize drug development This year InSysBio celebrates its 20-year anniversary. Now InSysBio specializes in Quantitative Systems Pharmacology (QSP) modeling services and QSP software infrastructure development and operates in the global market.
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
     
Upcoming Events
Tags